104 related articles for article (PubMed ID: 1683626)
41. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
Meltzer HY; Lee MA; Ranjan R; Mason EA; Cola PA
Psychopharmacology (Berl); 1996 Mar; 124(1-2):176-87. PubMed ID: 8935814
[TBL] [Abstract][Full Text] [Related]
42. Prolactin shifts after neuroleptic withdrawal.
Green AI; Faraone SV; Brown WA
Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
[TBL] [Abstract][Full Text] [Related]
43. RBC and plasma choline in neuroleptic-treated schizophrenic patients.
Lawson WB; Jeste DV; Hanin I; Kopp U; Wyatt RJ
Psychiatry Res; 1989 Jul; 29(1):45-53. PubMed ID: 2570429
[TBL] [Abstract][Full Text] [Related]
44. Symptomatology and electrodermal activity as predictors of neuroleptic response in young male schizophrenic inpatients.
Lindström EM; Ohlund LS; Lindström LH; Ohman A
Psychiatry Res; 1992 May; 42(2):145-58. PubMed ID: 1352902
[TBL] [Abstract][Full Text] [Related]
45. [Schizophrenia and amphetamine dependence. A case report].
Dervaux A; Krebs MO; Laqueille X
Encephale; 2005; 31(2):247-50. PubMed ID: 15959451
[TBL] [Abstract][Full Text] [Related]
46. Long-term neuroleptic treatment of chronic schizophrenic patients: clinical and biochemical effects of withdrawal.
Zander KJ; Fischer B; Zimmer R; Ackenheil M
Psychopharmacology (Berl); 1981; 73(1):43-7. PubMed ID: 6112769
[TBL] [Abstract][Full Text] [Related]
47. Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
Perényi A; Frecska E; Bagdy G; Révai K
Acta Psychiatr Scand; 1985 Nov; 72(5):430-5. PubMed ID: 2868608
[TBL] [Abstract][Full Text] [Related]
48. L-dopa challenge and relapse in schizophrenia.
Davidson M; Keefe RS; Mohs RC; Siever LJ; Losonczy MF; Horvath TB; Davis KL
Am J Psychiatry; 1987 Jul; 144(7):934-8. PubMed ID: 2886063
[TBL] [Abstract][Full Text] [Related]
49. Supersensitivity psychosis.
Peet M
J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
[No Abstract] [Full Text] [Related]
50. Performance of long-stay schizophrenics after drug withdrawal on matched immediate and delayed recall tasks.
Calev A; Nigal D; Kugelmass S; Weller MP; Lerer B
Br J Clin Psychol; 1991 Sep; 30(3):241-5. PubMed ID: 1681971
[TBL] [Abstract][Full Text] [Related]
51. Schizophrenic relapse after drug withdrawal is predictable.
Dencker SJ; Malm U; Lepp M
Acta Psychiatr Scand; 1986 Feb; 73(2):181-5. PubMed ID: 3705994
[TBL] [Abstract][Full Text] [Related]
52. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
[TBL] [Abstract][Full Text] [Related]
53. Subjective neuroleptic response and treatment outcome under open and double-blind conditions--a preliminary report.
Pi E; Sramek J; Johnson T; Herrera J; Heh C; Costa J; Cutler N; Ananth J
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):921-8. PubMed ID: 1980542
[TBL] [Abstract][Full Text] [Related]
54. A clinical trial of the effects of estrogen in acutely psychotic women.
Kulkarni J; de Castella A; Smith D; Taffe J; Keks N; Copolov D
Schizophr Res; 1996 Jul; 20(3):247-52. PubMed ID: 8827850
[TBL] [Abstract][Full Text] [Related]
55. Informed consent and bias in samples of schizophrenic subjects at risk for drug withdrawal.
Spohn HE; Fitzpatrick T
J Abnorm Psychol; 1980 Feb; 89(1):79-92. PubMed ID: 6102580
[No Abstract] [Full Text] [Related]
56. The effects of antipsychotic medication on sequential inhibitory processes.
Salo R; Robertson LC; Nordahl TE; Kraft LW
J Abnorm Psychol; 1997 Nov; 106(4):639-43. PubMed ID: 9358694
[TBL] [Abstract][Full Text] [Related]
57. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
Meltzer HY
Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845
[No Abstract] [Full Text] [Related]
58. Drug discontinuation among long term, successfully maintained schizophrenic outpatients.
Hogarty GE; Ulrich RF; Mussare F; Aristigueta N
Dis Nerv Syst; 1976 Sep; 37(9):494-500. PubMed ID: 971653
[No Abstract] [Full Text] [Related]
59. Neuroleptic withdrawal versus serotonergic syndrome in an 8-year-old child.
Godinho EM; Thompson AE; Bramble DJ
J Child Adolesc Psychopharmacol; 2002; 12(3):265-70. PubMed ID: 12427301
[TBL] [Abstract][Full Text] [Related]
60. Differential response to amphetamine in schizophrenia.
Cesarec Z; Nyman AK
Acta Psychiatr Scand; 1985 May; 71(5):523-38. PubMed ID: 2861718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
